These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 31793993)
21. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT. Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925 [TBL] [Abstract][Full Text] [Related]
22. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer. Zhang P; Tang WM; Zhang H; Li YQ; Peng Y; Wang J; Liu GN; Huang XT; Zhao JJ; Li G; Li AM; Bai Y; Chen Y; Ren YX; Li GX; Wang YD; Liu SD; Wang JD Br J Cancer; 2017 Aug; 117(4):525-534. PubMed ID: 28632723 [TBL] [Abstract][Full Text] [Related]
23. MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1. Xiang XJ; Deng J; Liu YW; Wan LY; Feng M; Chen J; Xiong JP Cell Physiol Biochem; 2015; 36(4):1382-94. PubMed ID: 26159618 [TBL] [Abstract][Full Text] [Related]
24. miR-345 inhibits migration and stem-like cell phenotype in gastric cancer via inactivation of Rac1 by targeting EPS8. Zhang J; Wang C; Yan S; Yang Y; Zhang X; Guo W Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):259-267. PubMed ID: 32147678 [TBL] [Abstract][Full Text] [Related]
25. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling. Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma. Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733 [TBL] [Abstract][Full Text] [Related]
27. Nonreceptor tyrosine phosphatase 14 promotes proliferation and migration through regulating phosphorylation of YAP of Hippo signaling pathway in gastric cancer cells. Han X; Sun T; Hong J; Wei R; Dong Y; Huang D; Chen J; Ren X; Zhou H; Tian W; Jia Y J Cell Biochem; 2019 Oct; 120(10):17723-17730. PubMed ID: 31168824 [TBL] [Abstract][Full Text] [Related]
28. CircRNA_0005075 suppresses carcinogenesis via regulating miR-431/p53/epithelial-mesenchymal transition axis in gastric cancer. Wu J; Chen Z; Song Y; Zhu Y; Dou G; Shen X; Zhou Y; Jiang H; Li J; Peng Y Cell Biochem Funct; 2020 Oct; 38(7):932-942. PubMed ID: 32133664 [TBL] [Abstract][Full Text] [Related]
29. MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9. Shang JC; Yu GZ; Ji ZW; Wang XQ; Xia L Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6160-6169. PubMed ID: 31364116 [TBL] [Abstract][Full Text] [Related]
30. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer. Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473 [TBL] [Abstract][Full Text] [Related]
31. The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis. Huang TT; Ping YH; Wang AM; Ke CC; Fang WL; Huang KH; Lee HC; Chi CW; Yeh TS Oncotarget; 2015 Jul; 6(20):18012-26. PubMed ID: 26041881 [TBL] [Abstract][Full Text] [Related]
32. The expression level changes of microRNAs 200a/205 in the development of invasive properties in gastric cancer cells through epithelial-mesenchymal transition. Mirzaei S; Baghaei K; Parivar K; Hashemi M; Asadzadeh Aghdaei H Eur J Pharmacol; 2019 Aug; 857():172426. PubMed ID: 31150646 [TBL] [Abstract][Full Text] [Related]
33. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis. Chen Z; Wu J; Huang W; Peng J; Ye J; Yang L; Yuan Y; Chen C; Zhang C; Cai S; He Y; Wu S; Song W Cell Physiol Biochem; 2018; 47(6):2432-2444. PubMed ID: 29991048 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. Xu M; Qin S; Cao F; Ding S; Li M Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929 [TBL] [Abstract][Full Text] [Related]
35. MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting Li J; Li T; Lu Y; Shen G; Guo H; Wu J; Lei C; Du F; Zhou F; Zhao X; Nie Y; Fan D FASEB J; 2017 Sep; 31(9):3774-3786. PubMed ID: 28512191 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-124 inhibits cell invasion and epithelial-mesenchymal transition by directly repressing Snail2 in gastric cancer. Li SL; Gao HL; Lv XK; Hei YR; Li PZ; Zhang JX; Lu N Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3389-3396. PubMed ID: 28829503 [TBL] [Abstract][Full Text] [Related]
37. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1]. Yang XY; Li N; Deng WY; Ma YJ; Han XL; Zhang ZY; Xie JL; Luo SX Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):193-199. PubMed ID: 30917455 [No Abstract] [Full Text] [Related]
38. MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer. Wu DM; Hong XW; Wang LL; Cui XF; Lu J; Chen GQ; Zheng YL Int J Biochem Cell Biol; 2018 Sep; 102():59-70. PubMed ID: 29953965 [TBL] [Abstract][Full Text] [Related]
39. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer. He C; Wang L; Zhang J; Xu H Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]